| Product Code: ETC9959314 | Publication Date: Sep 2024 | Updated Date: Apr 2026 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Summon Dutta | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
In 2024, the United States continued to see a significant influx of antibodies import shipments, with top exporting countries including Spain, Canada, Netherlands, UK, and Ireland. Despite high concentration levels indicated by the Herfindahl-Hirschman Index (HHI), the market maintained a strong compound annual growth rate (CAGR) of 11.87% from 2020 to 2024. However, there was a slight decline in growth rate from 2023 to 2024 at -10.81%, suggesting a potential shift in market dynamics. This data indicates a dynamic and competitive landscape for antibodies imports in the US market.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 United States (US) Antibodies Market Overview |
3.1 United States (US) Country Macro Economic Indicators |
3.2 United States (US) Antibodies Market Revenues & Volume, 2022 & 2032F |
3.3 United States (US) Antibodies Market - Industry Life Cycle |
3.4 United States (US) Antibodies Market - Porter's Five Forces |
3.5 United States (US) Antibodies Market Revenues & Volume Share, By Product, 2022 & 2032F |
3.6 United States (US) Antibodies Market Revenues & Volume Share, By Antibodes Type, 2022 & 2032F |
3.7 United States (US) Antibodies Market Revenues & Volume Share, By Technology, 2022 & 2032F |
3.8 United States (US) Antibodies Market Revenues & Volume Share, By Source, 2022 & 2032F |
3.9 United States (US) Antibodies Market Revenues & Volume Share, By Application, 2022 & 2032F |
3.10 United States (US) Antibodies Market Revenues & Volume Share, By End use, 2022 & 2032F |
4 United States (US) Antibodies Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of chronic diseases requiring antibody therapies |
4.2.2 Technological advancements in antibody development and manufacturing |
4.2.3 Rising investments in research and development for new antibody therapies |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for antibody approval |
4.3.2 High costs associated with antibody development and production |
4.3.3 Competition from biosimilar products impacting market share |
5 United States (US) Antibodies Market Trends |
6 United States (US) Antibodies Market, By Types |
6.1 United States (US) Antibodies Market, By Product |
6.1.1 Overview and Analysis |
6.1.2 United States (US) Antibodies Market Revenues & Volume, By Product, 2022 - 2032F |
6.1.3 United States (US) Antibodies Market Revenues & Volume, By Primary, 2022 - 2032F |
6.1.4 United States (US) Antibodies Market Revenues & Volume, By Secondary, 2022 - 2032F |
6.2 United States (US) Antibodies Market, By Antibodes Type |
6.2.1 Overview and Analysis |
6.2.2 United States (US) Antibodies Market Revenues & Volume, By Monoclonal Antibodies, 2022 - 2032F |
6.2.3 United States (US) Antibodies Market Revenues & Volume, By Polyclonal Antibodies, 2022 - 2032F |
6.3 United States (US) Antibodies Market, By Technology |
6.3.1 Overview and Analysis |
6.3.2 United States (US) Antibodies Market Revenues & Volume, By Immunohistochemistry, 2022 - 2032F |
6.3.3 United States (US) Antibodies Market Revenues & Volume, By Immunofluorescence, 2022 - 2032F |
6.3.4 United States (US) Antibodies Market Revenues & Volume, By Western Blotting, 2022 - 2032F |
6.3.5 United States (US) Antibodies Market Revenues & Volume, By Flow Cytometry, 2022 - 2032F |
6.3.6 United States (US) Antibodies Market Revenues & Volume, By Immunoprecipitation, 2022 - 2032F |
6.3.7 United States (US) Antibodies Market Revenues & Volume, By ELISA, 2022 - 2032F |
6.4 United States (US) Antibodies Market, By Source |
6.4.1 Overview and Analysis |
6.4.2 United States (US) Antibodies Market Revenues & Volume, By Mouse, 2022 - 2032F |
6.4.3 United States (US) Antibodies Market Revenues & Volume, By Rabbit, 2022 - 2032F |
6.4.4 United States (US) Antibodies Market Revenues & Volume, By Goat, 2022 - 2032F |
6.4.5 United States (US) Antibodies Market Revenues & Volume, By Others, 2022 - 2032F |
6.5 United States (US) Antibodies Market, By Application |
6.5.1 Overview and Analysis |
6.5.2 United States (US) Antibodies Market Revenues & Volume, By Infectious Diseases, 2022 - 2032F |
6.5.3 United States (US) Antibodies Market Revenues & Volume, By Immunology, 2022 - 2032F |
6.5.4 United States (US) Antibodies Market Revenues & Volume, By Oncology, 2022 - 2032F |
6.5.5 United States (US) Antibodies Market Revenues & Volume, By Stem Cells, 2022 - 2032F |
6.5.6 United States (US) Antibodies Market Revenues & Volume, By Neurobiology, 2022 - 2032F |
6.5.7 United States (US) Antibodies Market Revenues & Volume, By Others, 2022 - 2032F |
6.6 United States (US) Antibodies Market, By End use |
6.6.1 Overview and Analysis |
6.6.2 United States (US) Antibodies Market Revenues & Volume, By Academic & Research Institutes, 2022 - 2032F |
6.6.3 United States (US) Antibodies Market Revenues & Volume, By Contract Research Organizations, 2022 - 2032F |
6.6.4 United States (US) Antibodies Market Revenues & Volume, By Pharmaceutical & Biotechnology Companies, 2022 - 2032F |
7 United States (US) Antibodies Market Import-Export Trade Statistics |
7.1 United States (US) Antibodies Market Export to Major Countries |
7.2 United States (US) Antibodies Market Imports from Major Countries |
8 United States (US) Antibodies Market Key Performance Indicators |
8.1 Research and development expenditure in the antibody sector |
8.2 Number of patents filed for new antibody technologies |
8.3 Adoption rate of antibody therapies in key disease areas |
8.4 Success rate of clinical trials for antibody-based treatments |
8.5 Number of partnerships and collaborations in the antibody market |
9 United States (US) Antibodies Market - Opportunity Assessment |
9.1 United States (US) Antibodies Market Opportunity Assessment, By Product, 2022 & 2032F |
9.2 United States (US) Antibodies Market Opportunity Assessment, By Antibodes Type, 2022 & 2032F |
9.3 United States (US) Antibodies Market Opportunity Assessment, By Technology, 2022 & 2032F |
9.4 United States (US) Antibodies Market Opportunity Assessment, By Source, 2022 & 2032F |
9.5 United States (US) Antibodies Market Opportunity Assessment, By Application, 2022 & 2032F |
9.6 United States (US) Antibodies Market Opportunity Assessment, By End use, 2022 & 2032F |
10 United States (US) Antibodies Market - Competitive Landscape |
10.1 United States (US) Antibodies Market Revenue Share, By Companies, 2025 |
10.2 United States (US) Antibodies Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here